Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision entry updated to v3.6.6, replacing v3.6.5 in the page history. This reflects a minor system update to the history records and does not change study data or content.
    Difference
    0.1%
    Check dated 2026-08-31T17:19:32.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The history now includes a new revision label v3.6.5, replacing the previous v3.6.4 in the list.
    Difference
    0.1%
    Check dated 2026-08-10T17:42:33.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new revision label v3.6.4 was added to the study record history. The previous revision label v3.6.3 was removed from the history list.
    Difference
    0.1%
    Check dated 2026-07-27T06:29:37.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the history, and the previous v3.6.2 entry was removed, indicating an update to the study record.
    Difference
    0.1%
    Check dated 2026-07-05T13:30:19.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A newer revision (v3.6.2) was added to the study record history, and an older revision (v3.6.0) was removed, updating the version history.
    Difference
    0.1%
    Check dated 2026-06-28T08:19:14.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Recruitment status shows the study is no longer seeking participants, reflecting the current enrollment status. The record history updates to Revision: v3.6.0, superseding the prior Revision: v3.5.5 entry.
    Difference
    0.4%
    Check dated 2026-06-14T03:40:59.000Z thumbnail image

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.